Status:

UNKNOWN

Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study

Lead Sponsor:

King's College London

Collaborating Sponsors:

King's College Hospital NHS Trust

Conditions:

Multiple Sclerosis

Depression

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this pre-post observational study is to explore if it is feasible to implement 1) routine mental health screening and b) an online Cognitive Behavioural Therapy (CBT) treatment for anxiety ...

Detailed Description

The aim of the project is to conduct a feasibility study regarding the implementation of a) routine mental health screening and b) the COMPASS-MS programme as a low-intensity online CBT treatment for ...

Eligibility Criteria

Inclusion

  • Patients will be eligible for inclusion for the COMPASS-MS intervention if they are:
  • Aged ≥18 years
  • Have a diagnosis of MS.
  • Speak English to a sufficiently high standard to allow them to interact with digital CBT programmes.
  • Have access to a computer and email account to allow them to register with the digital CBT programme, and a basic understanding of internet use.
  • Presence of depression and/or anxiety and/or psychological distress evidenced by:
  • i. A score of ≥ 5 on the nine item self-report measure of depression: PHQ-9 (Kroenke et al., 2001) AND/OR ii. A score of ≥ 5 on the seven item self-report measure of anxiety: GAD-7 (Spitzer et al., 2006).
  • OR iii. A score of ≥ 10 on the composite measure of depression and anxiety PHQ-ADS (Kroenke et al., 2016).
  • AND iv. Distress is related to their MS (i.e. answer "yes" or "sometimes" to "Is your distress linked to your MS?"
  • The below eligibility criteria apply to HCPs who have experience in engaging with COMPASS-MS care pathways at King's College Hospital (KCH).
  • Healthcare providers (HCPs) will be eligible for inclusion if they meet all or any of the below criteria:
  • Work in the Neurology Service at KCH providing care to PwMS
  • Have experience of either: i) Assessing and triaging patients for psychological distress and/or ii) Providing therapist support to the users of COMPASS-MS.
  • Work in or alongside KCH who are implementing: i) Routine mental health screening ii) COMPASS digital CBT (e.g. pharmacy/physiotherapy commissioning bodies).
  • Key Stakeholder Inclusion Criteria
  • Key Stakeholders from Neurology services external to KCH will be invited to take part in an interview if they meet all or any of the below criteria:
  • Work in a Neurology Service in England including both inpatient services and MS therapy centres.
  • Have direct patient experience with working with PwMS (e.g. Neurologist, Doctor, Nurse, Reception)
  • Work alongside a Neurology services in England and are involved in the care of PwMS (e.g. pharmacy/physiotherapy/commissioning bodies).

Exclusion

    Key Trial Info

    Start Date :

    February 1 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 1 2025

    Estimated Enrollment :

    102 Patients enrolled

    Trial Details

    Trial ID

    NCT06222359

    Start Date

    February 1 2024

    End Date

    February 1 2025

    Last Update

    January 24 2024

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.